Showing results (101-110 of 1,291) with videos related to
Sort By:
Pageof 130
Veterinary and Comparative Oncology|September 18, 2018
Comparison of three mobilization protocols for peripheral blood stem cell apheresis with Spectra Optia continuous mononuclear cell protocol in healthy dogsSangho Kim, Kenji Hosoya, Ayumi Kobayashi, et al.Veterinary and Comparative Oncology|August 9, 2018
In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancersSita S Withers, Daniel York, Eric Johnson, et al.Veterinary and Comparative Oncology|May 4, 2017
High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survivalH Gregório, T Raposo, F L Queiroga, et al.Veterinary and Comparative Oncology|March 17, 2010
Feline intestinal sclerosing mast cell tumour: 50 cases (1997-2008)C H C Halsey, B E Powers, D A KamstockVeterinary and Comparative Oncology|September 1, 2016
A complication probability planning study to predict the safety of a new protocol for intracranial tumour radiotherapy in dogsC Rohrer Bley, V Meier, P Schwarz, et al.Veterinary and Comparative Oncology|May 18, 2019
Surgical decompression, with or without adjunctive therapy, for palliative treatment of primary vertebral osteosarcoma in dogsAlexandra Dixon, Annie Chen, John H Rossmeisl, et al.Veterinary and Comparative Oncology|May 18, 2019
Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomasKarin U Sorenmo, Amy C Durham, Veronica Kristiansen, et al.Veterinary and Comparative Oncology|May 10, 2019
Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018Felicia H Lew, Bobbi McQuown, Juan Borrego, et al.Veterinary and Comparative Oncology|May 10, 2019
Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signallingElpetra P M Timmermans-Sprang, Helena M Mestemaker, Renske R Steenlage, et al.Veterinary and Comparative Oncology|March 12, 2022
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disordersMiyuki Hirabayashi, James K Chambers, Akiyoshi Tani, et al.Pageof 130